Meridian Street Capital

Partners Scott Law and George Ribaroff, MD lead the investment function, per the firm’s website. Dr. Ribaroff’s clinical background — he holds an MD — anchors the firm’s ability to evaluate healthcare sciences. Venture Partner Jimmy Comfort extends the reach into deal sourcing and portfolio support.

Meridian Street Capital is structured as an asset manager and private equity firm, not a family office. Its small, named partnership and concentrated portfolio allow it to operate with the discretion and alignment profile often associated with a family-backed vehicle, but its capital base is not publicly linked to a single-family wealth origin.

The firm targets the earliest stages of company formation, explicitly supporting founders 'often from day one.' Its stated focus encompasses seed, start-up, and early-stage healthcare-technology ventures, moving deliberately to shape category-defining companies before traditional venture-scale syndicates commit.

The firm invests deliberately and solely at the intersection of healthcare and technology. It does not publish a broader sector mandate, distinguishing itself from generalist early-stage funds by concentrating exclusively on this vertical.

Neither assets under management nor disclosed portfolio company names are public as of the latest available data. The firm maintains a posture of privacy regarding its underlying capital base and scaled commitments, consistent with a concentrated partnership model rather than a fundraising-driven growth platform.